Vigil Neuroscience Ownership 2024 | Who Owns Vigil Neuroscience Now?
Institutional Ownership
65.27%
Insider Ownership
8.63%
Retail Ownership
26.10%
Institutional Holders
54.00
Vigil Neuroscience Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 14.64% | 2.46% | 5,836,874 | - | - | 23,347,496 | Jun 30, 2024 |
| NORTHPOND VENTURES, LLC | 10.57% | 30.50% | 4,214,498 | - | - | 16,857,992 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 4.59% | 0.19% | 1,828,691 | 17,500 | 0.97% | 7,314,764 | Jun 30, 2024 |
| BVF INC/IL | 4.55% | 0.20% | 1,813,633 | - | - | 7,254,532 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 4.24% | 0.92% | 1,692,166 | -38,248 | -2.21% | 6,768,664 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.73% | 0.02% | 1,485,000 | 1,485,000 | 100.00% | 5,940,000 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.76% | 0.33% | 1,100,000 | 105,100 | 10.56% | 4,400,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.04% | 0.00% | 814,731 | -79,742 | -8.91% | 3,258,924 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.87% | 0.88% | 744,412 | 744,412 | 100.00% | 2,977,648 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.50% | 0.07% | 597,215 | -997,716 | -62.56% | 2,388,860 | Jun 30, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.41% | 1.72% | 560,595 | - | - | 2,242,380 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.18% | 0.06% | 471,958 | - | - | 1,887,832 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.13% | 0.04% | 448,891 | - | - | 1,795,564 | Jun 30, 2024 |
| BLACKROCK INC. | 1.02% | - | 405,043 | -471,989 | -53.82% | 1,620,172 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.01% | 0.00% | 401,139 | 382,900 | 2099.35% | 1,604,556 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.99% | 0.00% | 395,116 | 166,442 | 72.79% | 1,580,464 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.84% | 0.00% | 334,807 | 301,678 | 910.62% | 1,339,228 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.73% | 0.01% | 289,460 | - | - | 1,157,840 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.52% | 0.01% | 206,614 | 206,614 | 100.00% | 826,456 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.40% | 0.00% | 159,371 | -174,871 | -52.32% | 637,622 | Jun 30, 2024 |
Vigil Neuroscience's largest institutional shareholder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, holding 14.64% of the company's total share outstanding, currently valued at $23.35M. The top 10 institutional shareholders own together 50.49% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORTHPOND VENTURES, LLC | 10.57% | 30.50% | 4,214,498 | - | - | 16,857,992 | Jun 30, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 14.64% | 2.46% | 5,836,874 | - | - | 23,347,496 | Jun 30, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.41% | 1.72% | 560,595 | - | - | 2,242,380 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 4.24% | 0.92% | 1,692,166 | -38,248 | -2.21% | 6,768,664 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.87% | 0.88% | 744,412 | 744,412 | 100.00% | 2,977,648 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.76% | 0.33% | 1,100,000 | 105,100 | 10.56% | 4,400,000 | Jun 30, 2024 |
| BVF INC/IL | 4.55% | 0.20% | 1,813,633 | - | - | 7,254,532 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 4.59% | 0.19% | 1,828,691 | 17,500 | 0.97% | 7,314,764 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.50% | 0.07% | 597,215 | -997,716 | -62.56% | 2,388,860 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.18% | 0.06% | 471,958 | - | - | 1,887,832 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.13% | 0.04% | 448,891 | - | - | 1,795,564 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.11% | 0.03% | 44,893 | 44,893 | 100.00% | 179,572 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.05% | 0.02% | 21,854 | 21,854 | 100.00% | 87,416 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.73% | 0.02% | 1,485,000 | 1,485,000 | 100.00% | 5,940,000 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.73% | 0.01% | 289,460 | - | - | 1,157,840 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.10% | 0.01% | 38,364 | 38,364 | 100.00% | 153,456 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.52% | 0.01% | 206,614 | 206,614 | 100.00% | 826,456 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.20% | 0.01% | 80,064 | 22,100 | 38.13% | 320,256 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.03% | 0.00% | 10,867 | -9,510 | -46.67% | 43,468 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.99% | 0.00% | 395,116 | 166,442 | 72.79% | 1,580,464 | Jun 30, 2024 |
The largest Vigil Neuroscience shareholder by % of total assets is NORTHPOND VENTURES, LLC. The company owns 4.21M shares of Vigil Neuroscience (VIGL), representing 30.50% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 3.73% | 0.02% | 1,485,000 | 1,485,000 | 100.00% | 5,940,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.87% | 0.88% | 744,412 | 744,412 | 100.00% | 2,977,648 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.01% | 0.00% | 401,139 | 382,900 | 2099.35% | 1,604,556 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.84% | 0.00% | 334,807 | 301,678 | 910.62% | 1,339,228 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.52% | 0.01% | 206,614 | 206,614 | 100.00% | 826,456 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.99% | 0.00% | 395,116 | 166,442 | 72.79% | 1,580,464 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 2.76% | 0.33% | 1,100,000 | 105,100 | 10.56% | 4,400,000 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.11% | 0.03% | 44,893 | 44,893 | 100.00% | 179,572 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.10% | 0.01% | 38,364 | 38,364 | 100.00% | 153,456 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.08% | 0.00% | 32,800 | 32,800 | 100.00% | 131,200 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.08% | 0.00% | 30,429 | 30,429 | 100.00% | 121,716 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.07% | 0.00% | 27,575 | 27,575 | 100.00% | 110,300 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.20% | 0.01% | 80,064 | 22,100 | 38.13% | 320,256 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.05% | 0.02% | 21,854 | 21,854 | 100.00% | 87,416 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.05% | - | 20,455 | 20,088 | 5473.57% | 82,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 4.59% | 0.19% | 1,828,691 | 17,500 | 0.97% | 7,314,764 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.04% | 0.00% | 16,609 | 16,609 | 100.00% | 66,436 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.18% | 0.00% | 71,500 | 11,536 | 19.24% | 286,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 8,135 | 8,135 | 100.00% | 32,540 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.07% | - | 26,797 | 7,858 | 41.49% | 107,188 | Jun 30, 2024 |
As of Jun 30 2024, Vigil Neuroscience's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 1.49M stocks of VIGL, valued at $5.94M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 1.50% | 0.07% | 597,215 | -997,716 | -62.56% | 2,388,860 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -980,311 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 1.02% | - | 405,043 | -471,989 | -53.82% | 1,620,172 | Jun 30, 2024 |
| STATE STREET CORP | 0.10% | - | 40,739 | -245,324 | -85.76% | 162,956,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.40% | 0.00% | 159,371 | -174,871 | -52.32% | 637,622 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.04% | 0.00% | 814,731 | -79,742 | -8.91% | 3,258,924 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -71,815 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.11% | 0.00% | 44,755 | -68,281 | -60.41% | 179,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -45,750 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -41,968 | -100.00% | - | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 4.24% | 0.92% | 1,692,166 | -38,248 | -2.21% | 6,768,664 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -33,368 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.03% | 0.00% | 12,065 | -32,933 | -73.19% | 48,260 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -26,840 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -19,178 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 2,588 | -15,365 | -85.58% | 10,352 | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 4,808 | -11,343 | -70.23% | 19,232 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.00% | - | 140 | -10,000 | -98.62% | 1,000 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.03% | 0.00% | 10,867 | -9,510 | -46.67% | 43,468 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -7,919 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Vigil Neuroscience's biggest institutional seller is DEEP TRACK CAPITAL, LP. The company sold -1.00M shares of VIGL, valued at $2.39M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 3.73% | 0.02% | 1,485,000 | 1,485,000 | 100.00% | 5,940,000 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.87% | 0.88% | 744,412 | 744,412 | 100.00% | 2,977,648 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.52% | 0.01% | 206,614 | 206,614 | 100.00% | 826,456 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.11% | 0.03% | 44,893 | 44,893 | 100.00% | 179,572 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.10% | 0.01% | 38,364 | 38,364 | 100.00% | 153,456 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.08% | 0.00% | 32,800 | 32,800 | 100.00% | 131,200 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.08% | 0.00% | 30,429 | 30,429 | 100.00% | 121,716 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.07% | 0.00% | 27,575 | 27,575 | 100.00% | 110,300 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.05% | 0.02% | 21,854 | 21,854 | 100.00% | 87,416 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.04% | 0.00% | 16,609 | 16,609 | 100.00% | 66,436 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 8,135 | 8,135 | 100.00% | 32,540 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.02% | 0.00% | 6,598 | 6,598 | 100.00% | 26,000 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 5,506 | 5,506 | 100.00% | 22,024 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.01% | 0.00% | 3,653 | 3,653 | 100.00% | 14,612 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.01% | - | 2,029 | 2,029 | 100.00% | 8,116 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 831 | 831 | 100.00% | 3,324 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 75 | 75 | 100.00% | 300 | Jun 30, 2024 |
Vigil Neuroscience's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 1.49M shares, valued at $5.94M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -980,311 | -100.00% | - | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | - | - | - | -71,815 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -45,750 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -41,968 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -33,368 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -26,840 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -19,178 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -7,919 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -7,700 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -5,655 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -1,554 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -1,327 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -542 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Vigil Neuroscience's largest sold out institutional shareholder by shares sold is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), sold -0.98M shares, valued at -, as of undefined.
Vigil Neuroscience Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.02% | 50,064 | -75,000 | -59.97% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 8,064 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,372 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,491 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 25,497 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 140,325 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 790,378 | -81,838 | -9.38% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 41,968 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 142,422 | 7,028 | 5.19% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,327 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 10,718 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,359 | 1,646 | 24.52% | Mar 31, 2024 |
| Global X Funds | 0.00% | 9,319 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,022 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 311 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 7,819 | -303 | -3.73% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,900 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 70,927 | 8,965 | 14.47% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 791 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 147 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 550,151 | -34,014 | -5.82% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 4,559 | -2,362 | -34.13% | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 29,351 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 700 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 6,167 | -24 | -0.39% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,643 | -26 | -0.97% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 73 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,301 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 125 | -9 | -6.72% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,353 | 279 | 13.45% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 10 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,735 | 119 | 7.36% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 22,032 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 5,791 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 570 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 13,600 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 33 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,820 | -8 | -0.44% | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 435 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 12,399 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 66 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 4,051 | 196 | 5.08% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 5,823 | -692 | -10.62% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 6,647 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 588 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 466 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,912 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,237 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,473 | - | - | Jan 31, 2024 |
Vigil Neuroscience's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 50.06K shares, compromising 0.02% of its total assets.
Vigil Neuroscience Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 54 | 3.85% |
| 31 Mar, 24 | 52 | 13.04% |
| 31 Dec, 23 | 46 | 2.22% |
| 30 Sep, 23 | 45 | -4.26% |
| 30 Jun, 23 | 47 | 14.63% |
| 31 Mar, 23 | 41 | 10.81% |
| 31 Dec, 22 | 37 | 23.33% |
| 30 Sep, 22 | 30 | -3.23% |
| 30 Jun, 22 | 31 | -34.04% |
| 31 Mar, 22 | 47 | - |
As of 30 Jun 24, 54 institutions are holding Vigil Neuroscience's shares, representing an increase of 3.85% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 26,018,839 | -1.88% |
| 31 Mar, 24 | 26,518,676 | 6.23% |
| 31 Dec, 23 | 24,962,629 | -2.27% |
| 30 Sep, 23 | 25,543,602 | -0.81% |
| 30 Jun, 23 | 25,751,059 | 2.73% |
| 31 Mar, 23 | 25,065,760 | 0.33% |
| 31 Dec, 22 | 24,984,471 | 1.75% |
| 30 Sep, 22 | 24,555,195 | 41.59% |
| 30 Jun, 22 | 17,342,208 | -2.90% |
| 31 Mar, 22 | 17,859,777 | - |
Vigil Neuroscience (VIGL) has 26.02M shares outstanding as of 30 Jun 24, down -1.88% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 65.27% | 1.39% |
| 31 Mar, 24 | 68.50% | 1.66% |
| 31 Dec, 23 | 64.32% | 1.47% |
| 30 Sep, 23 | 66.08% | 1.48% |
| 30 Jun, 23 | 66.81% | 1.58% |
| 31 Mar, 23 | 65.03% | 1.05% |
| 31 Dec, 22 | 78.85% | 1.45% |
| 30 Sep, 22 | 73.73% | 1.94% |
| 30 Jun, 22 | 61.61% | 1.37% |
| 31 Mar, 22 | 66.99% | - |
As of 30 Jun 24, Vigil Neuroscience is held by 65.27% institutional shareholders, representing a 1.39% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 29 | 45.00% |
| 31 Mar, 24 | 20 | -9.09% |
| 31 Dec, 23 | 22 | 37.50% |
| 30 Sep, 23 | 16 | -40.74% |
| 30 Jun, 23 | 27 | 80.00% |
| 31 Mar, 23 | 15 | -28.57% |
| 31 Dec, 22 | 21 | 31.25% |
| 30 Sep, 22 | 16 | 60.00% |
| 30 Jun, 22 | 10 | -78.72% |
| 31 Mar, 22 | 47 | - |
29 institutional shareholders have increased their position in VIGL stock as of 30 Jun 24 compared to 20 in the previous quarter (a 45.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | 13.33% |
| 31 Mar, 24 | 15 | 25.00% |
| 31 Dec, 23 | 12 | - |
| 30 Sep, 23 | 12 | 50.00% |
| 30 Jun, 23 | 8 | -20.00% |
| 31 Mar, 23 | 10 | 42.86% |
| 31 Dec, 22 | 7 | 133.33% |
| 30 Sep, 22 | 3 | -72.73% |
| 30 Jun, 22 | 11 | - |
| 31 Mar, 22 | - | - |
17 institutional shareholders have reduced their position in VIGL stock as of 30 Jun 24 compared to 15 in the previous quarter (a 13.33% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 54 | 3.85% | 26,018,839 | -1.88% | 65.27% | 1.39% | 29 | 45.00% | 17 | 13.33% |
| 31 Mar, 24 | 52 | 13.04% | 26,518,676 | 6.23% | 68.50% | 1.66% | 20 | -9.09% | 15 | 25.00% |
| 31 Dec, 23 | 46 | 2.22% | 24,962,629 | -2.27% | 64.32% | 1.47% | 22 | 37.50% | 12 | - |
| 30 Sep, 23 | 45 | -4.26% | 25,543,602 | -0.81% | 66.08% | 1.48% | 16 | -40.74% | 12 | 50.00% |
| 30 Jun, 23 | 47 | 14.63% | 25,751,059 | 2.73% | 66.81% | 1.58% | 27 | 80.00% | 8 | -20.00% |
| 31 Mar, 23 | 41 | 10.81% | 25,065,760 | 0.33% | 65.03% | 1.05% | 15 | -28.57% | 10 | 42.86% |
| 31 Dec, 22 | 37 | 23.33% | 24,984,471 | 1.75% | 78.85% | 1.45% | 21 | 31.25% | 7 | 133.33% |
| 30 Sep, 22 | 30 | -3.23% | 24,555,195 | 41.59% | 73.73% | 1.94% | 16 | 60.00% | 3 | -72.73% |
| 30 Jun, 22 | 31 | -34.04% | 17,342,208 | -2.90% | 61.61% | 1.37% | 10 | -78.72% | 11 | - |
| 31 Mar, 22 | 47 | - | 17,859,777 | - | 66.99% | - | 47 | - | - | - |
Vigil Neuroscience Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Vigil Neuroscience's stock was made by Vitorovic Stefan on May 07 2024, selling 13,928 shares at $10.00 per share (valued at $139.28K).
Vigil Neuroscience Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 35 | 28 | 125.00% |
| Q1 2024 | 8 | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | 8 | - | - |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 19 | - | - |
| Q1 2022 | 33 | 35 | 94.29% |
35 total buy trades, and 28 total sell trades (buy/sell ratio of 1.25%) were made by Vigil Neuroscience's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 1 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 7 | - | - |
| Q1 2022 | 9 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Vigil Neuroscience's stocks.
Vigil Neuroscience Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| PRTC | PureTech Health plc |
| EWTX | Edgewise Therapeutics, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| RLYB | Rallybio Corporation |
| TRDA | Entrada Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| PHVS | Pharvaris N.V. |
| PEPG | PepGen Inc. |
| THRD | Third Harmonic Bio, Inc. |
| MOLN | Molecular Partners AG |
| OPT | Opthea Limited |
| CMPX | Compass Therapeutics, Inc. |
VIGL Ownership FAQ
Who Owns Vigil Neuroscience?
Vigil Neuroscience is owned by institutional shareholders (65.27%), insiders (8.63%), and public (26.10%). The largest institutional shareholder of Vigil Neuroscience is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC (14.64% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.02% of total shares).
Who are the major institutional shareholders of Vigil Neuroscience?
Vigil Neuroscience's major institutional shareholders are ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, NORTHPOND VENTURES, LLC, ARTAL GROUP S.A., BVF INC/IL, and SPHERA FUNDS MANAGEMENT LTD.. The top five shareholders own together 38.60% of the company's share outstanding.
How many Vigil Neuroscience shareholders are there?
As of Jun 2024, there are 54 institutional shareholders of Vigil Neuroscience.
What percentage of Vigil Neuroscience is owned by ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC owns 5.84M shares of Vigil Neuroscience, representing 14.64% of the company's total shares outstanding, valued at $23.35M (as of Jun 2024).
What percentage of Vigil Neuroscience is owned by NORTHPOND VENTURES, LLC?
As of Jun 2024, NORTHPOND VENTURES, LLC holds 4.21M shares of Vigil Neuroscience (VIGL), compromising 10.57% of the company, valued at $16.86M.
What percentage of Vigil Neuroscience is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A is the third largest holder of Vigil Neuroscience. The company owns 1.83M of the company's shares outstanding (worth $7.31M).